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Background: Oesophagectomy is a major procedure with known side effects and reduced postoperative quality of
life (QOL). It has been shown that support of patients in their new life situation is often lacking. Knowledge about
how QOL changes over time is fundamental for addressing patient needs and for determining the optimal timing
of supportive care. The aim of this study was to identify QOL changes over time as well as factors that may impact
patient QOL during the first year after oesophagectomy for cancer.
Methods: Patients operated on for adenocarcinoma or squamous cell cancer of the oesophagus were included in
this study. Seventy-nine patients completed the European Organisation for Research and Treatment of Cancer QOL
questionnaires (QLQ-C30 and QLQ-OES18) before and 2, 4, 6, 9, and 12 months after surgery. A general linear model
with repeated measurement analysis of variance was used for statistical testing.
Results: There was a significant QOL nadir at 2 months compared to 12 months after surgery (QLQ-C30 function
scales p < 0.001, symptom scales p < 0.001, QLQ-OES18 scales p < 0.001). Treatment with proton-pump inhibitors was
associated with enhanced QOL according to QLQ-C30 symptom scales (p = 0.003) and OES-18 scales (p = 0.015), but
age, gender and American Society of Anaesthesiologists classification did not significantly impact QOL.
Conclusions: Patient QOL is severely hampered the first year after oesophagectomy for cancer, with a nadir at 2
months after surgery. Treatment with proton-pump inhibitors improved patient responses to symptom scales. Evidence
of severely affected QOL after surgery indicates that these patients need support at an early stage after surgery. These
results can be used by healthcare professionals to develop a postoperative supportive-care programme that is timed
and better optimised to meet patient needs. Trial registration: EudraCT database 2009-009997-28.
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Patients who have undergone oesophageal resections for
cancer experience reduced quality of life (QOL) over a
substantial period after surgery [1-6]. Patients face
extensive changes in their daily life after surgery, including
reduced physical and sometimes psychological capacities
[7-12], problems that may be underestimated by healthcare
providers. Several studies have focused on various
perspectives of QOL [1-6] as well as on associations
between e.g. QOL and disease characteristics [6]. However,* Correspondence: Marlene.malmstrom@med.lu.se
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reproduction in any medium, provided the orthere is a lack of knowledge about how patient QOL as a
total concept fluctuates during the first postoperative year.
This information is fundamental when aiming to develop a
supportive-care programme that is adjusted and timed
according to patient needs.
Oesophageal cancer is the eighth most common can-
cer worldwide [13]. After diagnosis with oesophageal
cancer, the first treatment option for patients is surgery.
Surgical resection with or without chemotherapy or che-
moradiotherapy is the mainstay therapy for cure [14].
Oesophageal resections are major surgical procedures
with long hospital stays and strenuous postoperative re-
habilitation. Compared with other gastrointestinal surgi-
cal procedures, recovery for oesophageal resection istral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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cer surgery has gradually improved, outcome in terms of
survival depends mainly on tumour stage at the time of
diagnosis [15]; the five-year survival rate remains only 31%
[16].
Outcomes after surgery may be expressed in terms of
survival rates, but also in terms of improvement in
QOL. In order to distinguish between QOL in the
broader sense and QOL connected with a patient’s
health, the concept of health-related QOL is often used
[17]. This parameter is a multidimensional construct
that refers to the ‘subjective evaluation of one’s ability to
perform usual tasks and their impact on one’s everyday
physical, emotional, and social well-being’ [18]. The present
study focuses on aspects of QOL connected with patient
health; therefore, in this study, QOL refers to patient
health-related QOL.
Symptoms associated with QOL in this patient group
are often divided into general symptoms (e.g. fatigue,
diarrhoea, appetite loss, and dyspnoea) and oesophageal-
specific symptoms (e.g. eating problems, reflux, cough, and
oesophageal pain) [1-4]. Nutrition problems (e.g. dysphagia,
weight loss, lack of appetite, changed sense of taste, or
dumping) [1,3,7,9-11,19-23] as well as problems with
changed bowel habits [1,2,8,10,23] are widely discussed
and are often highlighted as the dominating problems for
patients after surgery.
Previous studies have identified different and sometimes
contradictory factors that impact QOL. For example, age
[1,21], sex [21], co-morbidity, and tumour stage [24] have
been shown to affect QOL in some studies but not in
others. In a study by Johansson et al. [25], proton-pump
inhibitors (PPIs) were shown to exert a positive effect on
anastomotic strictures, indicating that the effect of PPIs
on QOL should be investigated.
To date, several studies have described the impact of
oesophageal cancer surgery on QOL. However, those
studies often focused on specific symptoms and functions
and even if they provided important knowledge about
patient life after surgery, they did not provide healthcare
workers with a clear picture of when patient life is most
severely affected. Knowledge about the timing of support
is greatly needed in order to optimise patient support after
surgery for oesophageal cancer.
AIM
The aim of this study was to identify QOL changes over
time as well as factors that may impact patient QOL
during the first year after oesophagectomy for cancer.
Methods
Study design, setting, and sample
This descriptive prospective study was a separate part of a
randomised controlled trial carried out at Skane UniversityHospital. The study was conducted with two separate aims:
(1) to conduct repeated assessments of health-related QOL
before and after surgery (addressed in the current study),
and (2) randomised controlled evaluation of the effects of
PPIs on postoperative anastomotic strictures [25]. There
were no major differences in the distribution of patient
demographics in the two randomised groups; therefore, in
the current study we evaluated both groups together and ad-
justed the results according to the randomisation. Since this
study was exploratory and lacked a control and a test group,
no power calculation was needed.
Briefly, patients were eligible for inclusion in this study if
they had undergone oesophageal resections with gastric-
tube reconstruction due to oesophageal cancer in the distal
oesophagus or at the gastro-oesophageal junction without
major postoperative complications and with tumour-free
resection margins (see list of inclusion and exclusion
criteria’s). During data collection, 129 patients were
available for inclusion. Forty-nine patients were excluded
due to in-hospital death (n = 1), anastomotic leaks (n = 2),
refusal to participate (n = 39), or other reasons (n = 7).
After confirming the exclusion criteria, 80 patients were
included in this study. One patient (n = 1) was excluded
due to failure to attend follow-up. Demographic data are
shown in Table 1.
List of inclusion and exclusion criteria’s
Inclusion criteria
Patients with tumours of any stage in the distal third of
the oesophagus, including type II tumours at the
gastro-oesophageal junction.
Transthoracic oesophageal resection with gastric-tube
reconstructions and circular stapled anastomoses in the
upper right chest.
Postoperative clinical courses without complications
and postoperative anastomotic radiograms without
anastomotic leakage.
Macro- and microscopically tumour-free upper resection
margins.
Willingness, physical and mental capability to comply
with randomisation, and ability to follow the study
protocol.
Age >18 years
Living in the south of Sweden (Skåne county)
Exclusion criteria
Preoperative or planned postoperative chemotherapy or
radiotherapy to the tumour area known at the time of
discharge from the hospital.
Postoperative need for continuous treatment with PPIs
or histamine-2 blockers or treatment with steroidal or
Table 1 Demographic characteristics of patients at










44.8-61.9 years 26 32.9
62.0-68.6 years 27 34.2







Control group (no treatment) 40 50.6




*American Society of Anaesthesiologists (ASA) physical status classification
system: 1 = normal healthy patient; 2 = patient with mild systemic disease;
3 = patient with severe systemic disease; 4 = patient with severe systemic
disease that is a constant threat to life.
Table 2 Answer frequency and drop outs over time (N = 79)
Time of
measurements
Answers Deceased Missing Answers
possible*
n % n n n %
Pre-operative 71 89.9 0 8
2 months 64 81.0 0 15
4 months 50 63.3 3 26 76 65.8
6 months 55 69.6 6 18 73 75.3
9 months 52 65.8 10 17 69 75.4
12 months 32 40.5 24 23 56 57.1
*Adjusted for deceased patients.
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occasional use.
Known allergy or side effects to PPIs preventing
continuous treatment for one year
Present drug or alcohol abuse
Failure to attend at least one postoperative visit
Patient recruitment began two days before discharge
from the hospital ward. All patients received both oral
and written information about the study before providing
informed consent. This study was conducted in accordance
with the Declaration of Helsinki [26], was approved by the
ethics committee at Lund University, Lund, Sweden
(LU-693-02), and was registered in the EudraCT database
(2009-009997-28) for clinical trials.
Data collection
All patients were asked to complete QOL questionnaires
before the operation and at 2, 4, 6, 9, and 12 months
after surgery. Questionnaires were sent to the patients
by mail and were sent back in an enclosed envelope.No reminders were sent out. Answer frequency appears
in Table 2.Instruments and measurements
Data collection was based on European Organisation for
Research and Treatment of Cancer (EORTC) validated
questionnaires. The general QOL questionnaire QLQ-C30
(version 3.0) and the oesophagus-specific module QLQ-
OES18 were used.
The EORTC QLQ-C30 questionnaire was developed
to assess health-related QOL in patients with cancer.
QLQ-C30 incorporates nine multi-item scales divided
into five functional scales (physical, role, emotional,
cognitive, and social), three symptom scales (fatigue,
nausea/vomiting, and pain), and a global health and
QOL scale. Several single-item symptom measures are
also included in this instrument [27].
EORTC diagnosis-specific modules have been developed
to cover specific diagnoses and to address symptoms and
concerns specific to patient groups. The oesophagus-
specific module QLQ-OES18 measures oesophageal
cancer-specific symptoms and assesses four symptom
scales (dysphagia, eating, reflux, and oesophageal pain)
and six single items (trouble swallowing saliva, choking,
dry mouth, taste, cough, and speech) [28]. Both QLQ-
OES18 and QLQ-C30 are based on a Likert scale. Before
analysis, patient responses were linearly transformed into
a 0–100 scale and further processed according to the
EORTC scoring manual [29]. High scores on symptom
scales indicate more symptoms, while high scores on
function scales indicate better function.
The American Society of Anaesthesiologists (ASA)
score was collected from patient medical records and
used in our statistical model as a potential impact factor.
The ASA score is a classification of the patient’s physical
status and ranges from 1 (‘normal healthy patient’) to six
(‘brain-dead patient’) [30]. In our model, we controlled
for ASA classifications 1 and 2 as separate variables and
ASA classifications 3–4 as one variable.
Age was categorized into three groups.
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Results from the QLQ-C30 and QLQ-OES18 question-
naires were transformed into function scales and symptom
scales according to instructions from the providers [27-29].
Imputation of missing values was done in two steps. Values
missing from completed questionnaires were replaced
according to the scoring manual of the instrument [29].
Missing values due to missing forms were replaced via
mean-value imputation. We sought to evaluate general
trends for the scales rather than to separately analyse each
transformed scale. A priori, we established three separate
statistical models: one for the set of function scales
(QLQ-C30) and two separate sets for the symptom
scales (QLQ-C30 and QLQ-OES18). Preoperative and
postoperative assessments at 2, 4, 6, 9, and 12 months
after surgery were included into each of the three statis-
tical models. A general linear model with repeated meas-
urement analysis of variance was used. Results from the
first postoperative year were evaluated as a composite
time parameter and adjusted for the following potential
impact factors: gender, age, ASA score, randomisation of
the study population (PPIs or no treatment), and whether
an anastomotic stricture appeared after surgery. Contrasts
were used to compare the results from each evaluated
pre- or postoperative occasion with the results of the
12-month assessments. Interaction analyses were carried
out between the composed time parameter and each of the
factors gender, age, ASA score, randomisation, and anasto-
motic stricture. The original data did not follow a perfect
normal distribution. However, repeated-measurements
analysis of variance was used due to its robustness to
deviations from the normal distribution and because
non-parametric statistical tests with this complex set-up
are not available. When Mauchly’s test of sphericity
indicated deviations from sphericity, adjustments of
the degrees of freedom were made according to the
Huynh-Feldt correction. Residuals were graphically
checked for constant variance, normality, independence,
and linearity. P-values <0.05 were considered significant.
Calculations were performed with the SPSS 18 package
(Chicago, USA).
Results
A total of 79 patients, mostly men (77.2%), were included
in this study. The mean age was 64.9 years, with a
standard deviation of 8.7 years (Table 1). The answer
frequency was 89.9% at baseline compared with 57.1%
at the 12-month follow-up (adjusted for deceased patients;
Table 2).
Results for the function scales (QLQ-C30) exhibited
an overall significant deviation in experienced function
levels over time (p = 0.006). This change manifested as a
significant peak of adverse functions at two months after
surgery versus 12 months after surgery (p < 0.001;Figure 1). Results were not significantly influenced by
gender (p = 0.379), age (p = 0.696), ASA score (p = 0.338),
randomisation (p = 0.081), or whether an anastomotic
stricture appeared after surgery (p = 0.732). Interaction
analyses indicated no additional interactions among the
evaluated variables during the study period.
Results for the QLQ-C30 symptom scales also indicated
an overall significant change in experienced symptoms
over time (p < 0.001), with a significant peak of symptoms
at two months after surgery compared to 12 months after
surgery (p < 0.001; Figure 2). Overall, results were
significantly impacted by the outcome of the random-
isation (PPIs or no treatment; p = 0.003), but not by
gender (p = 0.319), age (p = 0.696), ASA score
(p = 0.338), or whether an anastomotic stricture ap-
peared after surgery (p = 0.732). Interaction analyses indi-
cated no additional interactions among the evaluated
variables during the study period.
Results for the QLQ-OES18 symptom scales showed
an overall significant change in symptoms over time
(p < 0.001) with a significant peak of symptoms at two
months after surgery compared to 12 months after surgery
(p < 0.001; Figure 3). Results were significantly impacted
by randomisation to PPIs or to no treatment (p = 0.015),
but not by gender (p = 0.428), age (p = 0.812), ASA score
(p = 0.900), or whether an anastomotic stricture appeared
after surgery (p = 0.689). Interaction analyses indicated
that patients with anastomotic strictures had more ad-
verse symptoms at two months than at 12 months




In this study, EORTC questionnaires were used to evalu-
ate patient QOL, focusing on how symptoms and function
fluctuate over the first postoperative year. Earlier studies
reported that QOL is negatively affected after oesopha-
gectomy within specific symptom and function areas
[1-4,6], but no studies focused on when interventions are
most needed. In order to focus on when patient QOL is
most severely impaired during the first postoperative year,
we performed a composite analysis of the components of
the function and symptom scales instead of performing
multiple analyses of each individual component of the
scales. One potential limitation of this study is that it does
not yield information about specific symptoms or func-
tions. However, it provides a comprehensive picture of
how QOL changes over time –information that is
important when planning support interventions for these
patients. Another potential limitation is that information
about whether each patient lives alone was not available,

















Figure 1 Mean values of each QLQ-C30 function scale during the study year. There was a significant deviation at 2 months compared to
12 months after surgery (p < 0.001). For function scales, a high score indicates a high level of functioning. For global health status, a high score
indicates high QOL. Preop, preoperative.
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mised controlled trial of the effect of PPIs on anastomotic
strictures after oesophagetomy with gastric-tube recon-
structions [25]. The fact that this study was a part of a trial
in which patients were randomised to two arms (PPI treat-
ment or no treatment) could be a source of potential bias.
However, all patients selected for the study met the list of
inclusion criteria irrespective of the study arm into which
they were randomised. Since no major differences in the
distributions of demographics were identified between the
two arms (data not shown), all patients included in this
study were evaluated together. Final findings were adjusted
according to randomisation to PPI treatment or no treat-
ment; patients who received PPIs had better outcomes
than patients without PPIs. Hence, this study design en-
abled us to control for the potential impact of treatment
on patient QOL, a strength of this study.
During data collection, approximately 30% of the
included patients died, several due to relapse of their
cancer. It is realistic to believe that those patients
would have suffered from more symptoms than patients







Preop 2 months 4 months 6 months
Symptom scales QLQ-C30
Figure 2 Mean values of each QLQ-C30 symptom scale during the stu
12 months after surgery (p < 0.001). For symptom scales, a high score indicprobably have affected the answers of these patients, we
did not adjust this study accordingly.
Consideration of results
The results of this study indicated that patient QOL is
negatively affected after oesophagectomy, with a nadir at
two months compared to 12 months after surgery. These
dynamics are likely due to several factors, such as per-
sistent surgery-related ailments that exert both physical
and psychological effects; further, patients were dis-
charged from the ‘safe’ hospital setting, which included
all necessary support, and struggled to adapt to a new
life situation that included symptoms and ailments at
home [5,8]. Earlier studies have shown a complex picture
of patient QOL after oesophagectomy. Some studies re-
ported that QOL was satisfactory or good [22,31,32],
while others stated that it was reduced for a substan-
tial period after surgery [1-3,23]. Several studies fo-
cused on differences in patient QOL at various time
points after surgery [2,23,33]. In contrast to this study
six response measurements during the first postopera-










dy year. There was a significant deviation at 2 months compared to







Preop 2 months 4 months 6 months 9 months 12 months











Figure 3 Mean values for each QLQ-OES-18 symptom scale during the study year. There was a significant change at 2 months compared
to 12 months after surgery (p < 0.001). For symptom scales, a high score indicates more problems. Preop, pre-operative.
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urement points during follow-up, or focused on spe-
cific symptoms and functions. Our intensive following
of our patient group enabled us to draw more reliable
conclusions about how QOL changes during the first
postoperative year.
With good knowledge of underlying relevant factors
that impact patient QOL, healthcare professionals can
better tailor postoperative supportive-care programmes.
This study demonstrated that treatment with PPIs, but not
age, gender, or ASA classification, significantly impacted
patient QOL (symptom scales). Gastro-oesophageal
reflux is a prominent problem for this patient group
[1,3,21]. For example, Lagergren et al. [3] reported
that patients suffered from problems with reflux as
long as 3 years after surgery. Taken together, these re-
sults suggest that treatment with PPIs has a positive
impact on patient QOL and lowers the risk of
oesophageal strictures after surgery [25]. Thus, PPIs
could be recommended during the first postoperative
year.
Earlier studies of patient experiences concluded that
patients require support in handling persistent problems
after surgery [34] and that postoperative support should
address the patients’ physical, psychological, and social
concerns [12,34]. The current study demonstrated that
patient QOL is most severely reduced 2 months after
surgery, which indicates that patients need support at an
early stage. Supportive-care programmes within other
cancer contexts exerted positive effects on QOL [35,36],
reduced unmet supportive-care needs, and improved
continuity of care [35]. However, earlier intervention
studies that sought to support these patients after surgery
reported divergent results on QOL [37-39]. Since our
study showed that patient QOL is most severely hampered
two months after surgery, the timing of support after
surgery is essential. The current study suggests a
great need for proactive supportive-care programmesfor these patients; in hospital, patients should be prepared
for life after surgery, and after discharge, physical and
psychological support should be provided to patients
in their new life situation. We therefore suggest en-
hancing patient QOL by combining a supportive-care
programme (including a discharge meeting focusing
on the post-surgery period) with nurse-led proactive
telephone contacts that address individual needs during
the first year after surgery. Further studies testing such a
programme are needed.Conclusions
The current study demonstrates that patient QOL is
severely reduced during the first year after oesophagectomy
for cancer, with a nadir at 2 months after surgery. Treat-
ment with PPIs improves patient responses on symptom
scales. The severe effect on QOL after surgery indicates
that these patients need support soon after surgery. These
results can be used to help healthcare professionals develop
postoperative supportive-care programmes that are better
timed and optimised to patient needs.Competing interests
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